What is the share price of GPT Healthcare Ltd (GPTHEALTH) today?
The share price of GPTHEALTH as on 29th April 2025 is ₹156.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on GPT Healthcare Ltd (GPTHEALTH) share?
The past returns of GPT Healthcare Ltd (GPTHEALTH) share are- Past 1 week: -4.41%
- Past 1 month: 13.77%
- Past 3 months: -0.10%
- Past 6 months: 0.26%
- Past 1 year: -6.65%
- Past 3 years: N/A%
- Past 5 years: -19.74%
What are the peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH)?
The peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH) include:What is the dividend yield % of GPT Healthcare Ltd (GPTHEALTH) share?
The current dividend yield of GPT Healthcare Ltd (GPTHEALTH) is 2.17.What is the market cap of GPT Healthcare Ltd (GPTHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of GPT Healthcare Ltd (GPTHEALTH) is ₹1321.74 Cr as of 29th April 2025.What is the 52 week high and low of GPT Healthcare Ltd (GPTHEALTH) share?
The 52-week high of GPT Healthcare Ltd (GPTHEALTH) is ₹208.45 and the 52-week low is ₹126.10.What is the PE and PB ratio of GPT Healthcare Ltd (GPTHEALTH) stock?
The P/E (price-to-earnings) ratio of GPT Healthcare Ltd (GPTHEALTH) is 27.67. The P/B (price-to-book) ratio is 6.05.Which sector does GPT Healthcare Ltd (GPTHEALTH) belong to?
GPT Healthcare Ltd (GPTHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy GPT Healthcare Ltd (GPTHEALTH) shares?
You can directly buy GPT Healthcare Ltd (GPTHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
GPT Healthcare Ltd
GPTHEALTH Share Price
GPTHEALTH Share Price Chart
How to use scorecard? Learn more
GPTHEALTH Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
26.50 | 6.05 | 2.17% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
50.16 | 6.42 | 0.53% |
GPTHEALTH Analyst Ratings & Forecast
Detailed Forecast from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
GPTHEALTH Company Profile
GPT Healthcare is engaged in the operation of multidisciplinary private hospitals and pharmacies.
Investor Presentation
View olderGPTHEALTH Similar Stocks (Peers)
Compare with peersGPTHEALTH Sentiment Analysis
GPTHEALTH Stock Summary · November 2024
The company demonstrated robust financial performance with a 10% year-over-year increase in Profit After Tax for Q2 FY25, driven by operational efficiencies such as a reduced average length of stay and a significant 58% decrease in finance costs. While patient volumes have surged in certain areas, particularly for short-stay surgeries, challenges persist with declining occupancy rates and flat revenue growth in the first half of the year, exacerbated by local issues and regulatory delays. Strategic investments in advanced medical technologies and the introduction of specialized services, including oncology, are expected to enhance patient engagement and revenue generation. Management remains optimistic about achieving double-digit growth in the latter half of the fiscal year, despite a competitive landscape marked by recent acquisitions.
Key Points on Gpthealth Stock
GPTHEALTH Stock Growth Drivers
5Financial Performance Improvements
GPT Healthcare Limited has reported significant financial achievements, including a 10% year-on-year increase in Profit
Operational Efficiency and Service Optimization
The company has successfully reduced its average length of stay (ALOS) to 3.31 days from
GPTHEALTH Stock Challenges
4Flat Revenue Growth
Despite a reported increase in Profit After Tax (PAT) and improvements in operational metrics such
Occupancy Rate Challenges
The company reported a bed occupancy rate of only 54% across its facilities, which is
GPTHEALTH Forecasts
Price
Revenue
Earnings
GPTHEALTH Share Price Forecast
All values in ₹
All values in ₹
GPTHEALTH Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
GPTHEALTH Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
GPTHEALTH
Income
Balance Sheet
Cash Flow
GPTHEALTH Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 216.07 | 248.86 | 342.40 | 366.73 | 405.48 | 413.64 | ||||||
Raw Materials | 38.41 | 57.27 | 87.38 | 75.86 | 82.96 | 319.27 | ||||||
Power & Fuel Cost | 6.19 | 6.80 | 7.42 | 8.08 | 9.53 | |||||||
Employee Cost | 42.04 | 41.66 | 53.78 | 62.04 | 68.93 | |||||||
Selling & Administrative Expenses | 19.04 | 22.49 | 9.36 | 12.92 | 11.84 | |||||||
Operating & Other expenses | 70.36 | 65.54 | 105.64 | 127.78 | 139.09 | |||||||
EBITDA | 40.03 | 55.10 | 78.82 | 80.05 | 93.13 | 94.37 | ||||||
Depreciation/Amortization | 11.08 | 12.47 | 13.59 | 14.91 | 17.98 | 18.91 | ||||||
PBIT | 28.95 | 42.63 | 65.23 | 65.14 | 75.15 | 75.46 | ||||||
Interest & Other Items | 14.12 | 13.75 | 11.15 | 9.16 | 7.11 | 4.04 | ||||||
PBT | 14.83 | 28.88 | 54.08 | 55.98 | 68.04 | 71.42 | ||||||
Taxes & Other Items | 3.88 | 7.79 | 12.41 | 16.96 | 20.27 | 21.54 | ||||||
Net Income | 10.95 | 21.09 | 41.67 | 39.02 | 47.77 | 49.88 | ||||||
EPS | 2.03 | 3.92 | 6.23 | 4.88 | 5.90 | 6.08 | ||||||
DPS | 0.00 | 1.83 | 0.00 | 5.00 | 3.50 | 3.50 | ||||||
Payout ratio | 0.00 | 0.47 | 0.00 | 1.02 | 0.59 | 0.58 |
GPTHEALTH Company Updates
GPTHEALTH Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
GPT Healthcare Ltd | 27.67 | 6.05 | 2.17% |
Max Healthcare Institute Ltd | 101.09 | 12.72 | 0.14% |
Apollo Hospitals Enterprise Ltd | 112.73 | 13.84 | 0.23% |
Fortis Healthcare Ltd | 85.12 | 5.96 | 0.15% |
GPTHEALTH Stock Price Comparison
Compare GPTHEALTH with any stock or ETFGPTHEALTH Shareholdings
GPTHEALTH Promoter Holdings Trend
GPTHEALTH Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
GPTHEALTH Shareholding Pattern
GPTHEALTH Shareholding History
Mutual Funds Invested in GPTHEALTH
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding GPT Healthcare Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.6906% | Percentage of the fund’s portfolio invested in the stock 0.23% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 85/200 (+45) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1154% | Percentage of the fund’s portfolio invested in the stock 0.19% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 69/101 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0859% | Percentage of the fund’s portfolio invested in the stock 0.18% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 100/166 (-2) |
Compare 3-month MF holding change on Screener
smallcases containing GPTHEALTH stock
Looks like this stock is not in any smallcase yet.
GPTHEALTH Events
GPTHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
GPTHEALTH Upcoming Dividends
No upcoming dividends are available
GPTHEALTH Past Dividends
Cash Dividend
Ex DateEx DateNov 28, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Nov 28, 2024
Cash Dividend
Ex DateEx DateJul 18, 2024
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateApr 2, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Apr 2, 2024
GPTHEALTH Stock News & Opinions
Net profit of GPT Healthcare rose 6.80% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 11.47 crore during the previous quarter ended December 2023. Sales rose 5.82% to Rs 102.21 crore in the quarter ended December 2024 as against Rs 96.59 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales102.2196.59 6 OPM %20.8021.74 - PBDT22.2920.49 9 PBT17.6215.99 10 NP12.2511.47 7 Powered by Capital Market - Live
GPT Healthcare will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live
The facility, which will be fully equipped with modern amenities and services, is intended to be leased to GPT Healthcare on a long-term basis. The agreement involves multiple parties, including Naveen Singh, Ankur Singh, Shruti Singh, Vinayak Singh, Akshat Singh, Avinash Gaurav, and Kavita Singh. The company has clarified that the agreement is with a third party, assuring there is no conflict of interest and no nominees from the third party are on the company's board of directors. GPT Healthcare, the healthcare arm of the GPT Group, currently owns and operates over 561 beds spread across four state-of-the-art multi-specialty hospitals in the eastern part of the country under the brand name ILS Hospitals. Founded in 2000 in Salt Lake, Kolkata, ILS Hospitals has since expanded its footprint and capabilities. The company's standalone net profit increased 9.8% to Rs 14.82 crore in Q2 FY25 as against Rs 13.50 crore posted in Q2 FY24. However, revenue from operations shed 2.1% YoY to Rs 105.66 in the quarter ended 30 September 2024. Powered by Capital Market - Live
The key equity indices traded with minor gains in early trade. The Nifty traded above the 24,700 level. FMCG, metal and auto shares advanced while IT, realty and media stocks corrected. Investors are awaiting for the outcome of today's RBI Monetary Policy Committee meeting. At 09:29 IST, the barometer index, the S&P BSE Sensex rose 61.13 points or 0.08% to 81,826.99. The Nifty 50 index added 3.60 points or 0.01% to 24,712. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.09% and the S&P BSE Small-Cap index rallied 0.32%. The market breadth was strong. On the BSE, 2,027 shares rose and 917 shares fell. A total of 107 shares were unchanged. Foreign portfolio investors (FPIs) bought shares worth Rs 8,539.91 crore, while domestic institutional investors (DIIs) were net sellers to the tune of Rs 2,303.64 crore in the Indian equity market on 5 December 2024, provisional data showed. Stocks in Spotlight: GPT Healthcare rose 0.94%. The company has entered into memorandum of Understanding (MoU) for the construction and finishing of a hospital building at Jamshedpur, Jharkhand. Canara Bank added 0.51%. The bank said that the Reserve Bank of India (RBI) has approved to divest its 13% stake in Canara Robeco Asset Management Company and 14.5% in Canara HSBC Life Insurance Company through Initial Public Offer (IPO). The bank has been instructed to adhere to 31 October 2029, timeline for reducing stake in the said entities to 30%. FSN E-Commerce Ventures (Nykaa) shed 0.93%. Nikhil Parikh has resigned from his position as chief executive officer (CEO) of Nykaa Fashion.com Numbers to Track: The yield on India's 10-year benchmark federal paper rose 0.05% to 6.793 as compared with previous close 6.789. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 84.6600, compared with its close of 84.7100 during the previous trading session. MCX Gold futures for 5 February 2024 settlement was added 0.35% to Rs 76,744. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.08% to 105.80. The United States 10-year bond yield fell 0.17% to 4.173. In the commodities market, Brent crude for January 2024 settlement lost 06 cents or 0.08% to $72.03 a barrel. Global Markets: Asian stocks traded mixed on Friday. All eyes are on the U.S. nonfarm payrolls report due in the day that may help shape the direction of the Federal Reserve's policy path later this month. In Asia, key economic data releases include India's interest rate decision and Malaysia's foreign reserves. China's November foreign reserves data may also be released today. US stock markets pulled back from record highs on Thursday as investors took a cautious approach ahead of the payrolls report. The S&P 500 declined 0.2%, the NASDAQ Composite fell 0.2%, and the Dow Jones Industrial Average dropped 0.6%. Technology stocks, a major driver of recent market gains, retreated, while economically sensitive sectors like energy, financials, and industrials also lost ground. US initial jobless claims rose to 224,000 for the week ended November 30th, up from the previous week's revised figure of 215,000. The upcoming US nonfarm payrolls report will be closely watched by investors and policymakers alike. A strong reading could reinforce expectations of economic recovery and support further normalization of monetary policy. Meanwhile Bitcoin tumbled from record highs above the coveted $100,000 level, as it was slapped with heavy profit-taking. Powered by Capital Market - Live
Securities in F&O Ban: Granules India and Manapurram Finance shares were banned from F&O trading on 6 December 2024. Stocks to Watch: GPT Healthcare has entered into memorandum of Understanding (MoU) for the construction anf finishing of a hospital building at Jamshedpur, Jharkhand. Canara Bank said that Reserve Bank of India (RBI) has approved to divest its 13% stake inCanara Robeco Asset Management Company and 14.5% in Canara HSBC Life Insurance Company through Initial Public Offer (IPO). The bank has been instructed to adhere to 31 October 2029, timeline for reducing stake in the said entities to 30%. FSN E-Commerce Ventures (Nykaa)'s Nikhil Parikh has resigned from his position as chief executive officer (CEO) of Nykaa Fashion.com Cummins India's chief financial officer, Ajay Shriram Patil has resigned due to personal reasons, with effect from 9 January 2025. Garden Reach Shipbuilder & Engineer (GRSE) has signed contract for the construction and delivery of the second ship from a series of four additional 7,500 DWT multi-purpose vessels in Germany. In September, the company had secured an order for the construction and delivery of four additional multi-purpose vessels of 7,500 DWT each. Ramco Systems has entered a partnership with Hanjin Information Systems and Telecommunication, a subsidiary of the Hanjin Group. Together, both the parties will enable the aviation organizations headquartered in South Korea to digitally transform their M&E and MRO operations. Welspun Living's board approved the scheme of amalgamation between Welspun Home Solutions and Welspun Advanced Materials. Welspun Home Solutions is a subsidiary of Welspun Advanced Materials.Powered by Capital Market - Live
Net profit of GPT Healthcare rose 9.78% to Rs 14.82 crore in the quarter ended September 2024 as against Rs 13.50 crore during the previous quarter ended September 2023. Sales declined 2.15% to Rs 105.66 crore in the quarter ended September 2024 as against Rs 107.98 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales105.66107.98 -2 OPM %22.1722.77 - PBDT25.4923.87 7 PBT20.6919.48 6 NP14.8213.50 10 Powered by Capital Market - Live
GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 14 November 2024, has recommended a First Interim dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.Powered by Capital Market - Live
GPT Healthcare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Net profit of GPT Healthcare declined 0.20% to Rs 9.96 crore in the quarter ended June 2024 as against Rs 9.98 crore during the previous quarter ended June 2023. Sales rose 1.68% to Rs 97.82 crore in the quarter ended June 2024 as against Rs 96.20 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales97.8296.20 2 OPM %18.3619.83 - PBDT19.3418.50 5 PBT14.6614.16 4 NP9.969.98 0 Powered by Capital Market - Live
GPT Healthcare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant